22 December 2015 - Deborah Wilkes
Archived
Goldman Sachs and private-equity firm Astorg Asset Management may be about to acquire control of HRA Pharma, which recently switched the ellaOne (ulipristal acetate) emergency contraceptive from prescription to non-prescription status in the European Union.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.